Fig. 4From: The effect of genetically modified platelet-derived growth factor-BB over-expressing mesenchymal stromal cells during core decompression for steroid-associated osteonecrosis of the femoral head in rabbitsMicroCT analysis. BVF and BMD were assessed using micro-CT. a Representative images of the femoral head for each treatment group are shown. b Within the CD area, no significant differences were observed between treatment groups. c Outside of the CD area, the PGK-PDGF-BB-MSC group demonstrated a trend towards greater BMD than the CD group (P = 0.07). No differences were noted between treatment groups with regards to BVF. CD core decompression, HG hydrogel, MSC mesenchymal stromal cell, PGK-PDGF-BB-MSC genetically modified phosphoglycerate kinase promoter platelet-derived growth factor-BB over-expressing MSC, BMD bone mineral density, BVF bone volume fractionBack to article page